HEADER TRANSFERASE 03-JUN-16 5KBQ TITLE PAK1 IN COMPLEX WITH BIS-ANILINO PYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALPHA-PAK,P21-ACTIVATED KINASE 1,PAK-1,P65-PAK; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE/THREONINE-PROTEIN KINASE PAK1, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.FERGUSON REVDAT 3 27-SEP-23 5KBQ 1 REMARK REVDAT 2 11-JAN-17 5KBQ 1 JRNL REVDAT 1 28-SEP-16 5KBQ 0 JRNL AUTH W.MCCOULL,E.J.HENNESSY,K.BLADES,C.CHUAQUI,J.E.DOWLING, JRNL AUTH 2 A.D.FERGUSON,F.W.GOLDBERG,N.HOWE,C.R.JONES,P.D.KEMMITT, JRNL AUTH 3 G.LAMONT,J.G.VARNES,R.A.WARD,B.YANG JRNL TITL OPTIMIZATION OF HIGHLY KINASE SELECTIVE BIS-ANILINO JRNL TITL 2 PYRIMIDINE PAK1 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 7 1118 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 27994749 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00322 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 19559 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1004 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.01 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2766 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2270 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2634 REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE : 0.3260 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.77 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4400 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 49 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 77.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.86400 REMARK 3 B22 (A**2) : -1.58120 REMARK 3 B33 (A**2) : 5.44520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -12.03590 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.627 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.275 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.749 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.284 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4508 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6096 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1627 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 125 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 651 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4508 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 596 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5217 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.22 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.01 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 22.77 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -1.8125 -23.2628 14.8901 REMARK 3 T TENSOR REMARK 3 T11: -0.1928 T22: -0.2525 REMARK 3 T33: -0.2698 T12: -0.0500 REMARK 3 T13: 0.0592 T23: -0.0098 REMARK 3 L TENSOR REMARK 3 L11: 3.7060 L22: 3.9131 REMARK 3 L33: 5.7544 L12: 0.1587 REMARK 3 L13: -2.0336 L23: -1.0602 REMARK 3 S TENSOR REMARK 3 S11: -0.1225 S12: 0.1114 S13: -0.4785 REMARK 3 S21: 0.0503 S22: 0.0086 S23: 0.2126 REMARK 3 S31: -0.0587 S32: -0.3259 S33: 0.1139 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 31.0055 22.4973 15.1590 REMARK 3 T TENSOR REMARK 3 T11: -0.0320 T22: -0.1432 REMARK 3 T33: -0.0863 T12: 0.0875 REMARK 3 T13: 0.1518 T23: 0.0433 REMARK 3 L TENSOR REMARK 3 L11: 1.1410 L22: 2.0574 REMARK 3 L33: 1.8807 L12: 1.0965 REMARK 3 L13: -0.2160 L23: 0.4114 REMARK 3 S TENSOR REMARK 3 S11: -0.0332 S12: -0.1885 S13: 0.0314 REMARK 3 S21: 0.2154 S22: -0.0464 S23: 0.3631 REMARK 3 S31: 0.2029 S32: -0.1336 S33: 0.0796 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KBQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000221997. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19584 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 63.110 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.86200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4P90 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULPHATE, 16% PEG 3350, REMARK 280 0.1M HEPES (PH 7.6), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.47000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU B 254 REMARK 465 GLN B 278 REMARK 465 GLY B 279 REMARK 465 ALA B 280 REMARK 465 SER B 281 REMARK 465 PHE B 408 REMARK 465 GLY B 409 REMARK 465 PHE B 410 REMARK 465 CYS B 411 REMARK 465 ALA B 412 REMARK 465 GLN B 413 REMARK 465 ILE B 414 REMARK 465 THR B 415 REMARK 465 PRO B 416 REMARK 465 GLU B 417 REMARK 465 GLN B 418 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 306 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 302 102.64 72.72 REMARK 500 LYS A 309 -43.06 79.63 REMARK 500 LEU A 331 -75.96 -104.19 REMARK 500 ASP A 338 -14.40 64.67 REMARK 500 ASN A 389 40.13 -145.27 REMARK 500 ASP A 407 86.20 54.40 REMARK 500 MET A 424 83.58 -64.54 REMARK 500 LYS A 444 -8.09 -55.55 REMARK 500 ILE B 276 -71.37 -107.77 REMARK 500 THR B 283 107.83 68.06 REMARK 500 LEU B 303 26.14 -71.41 REMARK 500 LYS B 308 38.89 -80.39 REMARK 500 ARG B 388 -12.72 73.42 REMARK 500 LEU B 484 123.70 -37.73 REMARK 500 THR B 541 55.38 -97.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 717 DISTANCE = 6.17 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IPV A 601 DBREF 5KBQ A 254 542 UNP Q13153 PAK1_HUMAN 254 542 DBREF 5KBQ B 254 542 UNP Q13153 PAK1_HUMAN 254 542 SEQADV 5KBQ ASN A 389 UNP Q13153 ASP 389 ENGINEERED MUTATION SEQADV 5KBQ GLU A 423 UNP Q13153 THR 423 ENGINEERED MUTATION SEQADV 5KBQ ASP A 503 UNP Q13153 GLU 503 ENGINEERED MUTATION SEQADV 5KBQ ASN B 389 UNP Q13153 ASP 389 ENGINEERED MUTATION SEQADV 5KBQ GLU B 423 UNP Q13153 THR 423 ENGINEERED MUTATION SEQADV 5KBQ ASP B 503 UNP Q13153 GLU 503 ENGINEERED MUTATION SEQRES 1 A 289 LEU GLU LYS LEU ARG SER ILE VAL SER VAL GLY ASP PRO SEQRES 2 A 289 LYS LYS LYS TYR THR ARG PHE GLU LYS ILE GLY GLN GLY SEQRES 3 A 289 ALA SER GLY THR VAL TYR THR ALA MET ASP VAL ALA THR SEQRES 4 A 289 GLY GLN GLU VAL ALA ILE LYS GLN MET ASN LEU GLN GLN SEQRES 5 A 289 GLN PRO LYS LYS GLU LEU ILE ILE ASN GLU ILE LEU VAL SEQRES 6 A 289 MET ARG GLU ASN LYS ASN PRO ASN ILE VAL ASN TYR LEU SEQRES 7 A 289 ASP SER TYR LEU VAL GLY ASP GLU LEU TRP VAL VAL MET SEQRES 8 A 289 GLU TYR LEU ALA GLY GLY SER LEU THR ASP VAL VAL THR SEQRES 9 A 289 GLU THR CYS MET ASP GLU GLY GLN ILE ALA ALA VAL CYS SEQRES 10 A 289 ARG GLU CYS LEU GLN ALA LEU GLU PHE LEU HIS SER ASN SEQRES 11 A 289 GLN VAL ILE HIS ARG ASN ILE LYS SER ASP ASN ILE LEU SEQRES 12 A 289 LEU GLY MET ASP GLY SER VAL LYS LEU THR ASP PHE GLY SEQRES 13 A 289 PHE CYS ALA GLN ILE THR PRO GLU GLN SER LYS ARG SER SEQRES 14 A 289 GLU MET VAL GLY THR PRO TYR TRP MET ALA PRO GLU VAL SEQRES 15 A 289 VAL THR ARG LYS ALA TYR GLY PRO LYS VAL ASP ILE TRP SEQRES 16 A 289 SER LEU GLY ILE MET ALA ILE GLU MET ILE GLU GLY GLU SEQRES 17 A 289 PRO PRO TYR LEU ASN GLU ASN PRO LEU ARG ALA LEU TYR SEQRES 18 A 289 LEU ILE ALA THR ASN GLY THR PRO GLU LEU GLN ASN PRO SEQRES 19 A 289 GLU LYS LEU SER ALA ILE PHE ARG ASP PHE LEU ASN ARG SEQRES 20 A 289 CYS LEU ASP MET ASP VAL GLU LYS ARG GLY SER ALA LYS SEQRES 21 A 289 GLU LEU LEU GLN HIS GLN PHE LEU LYS ILE ALA LYS PRO SEQRES 22 A 289 LEU SER SER LEU THR PRO LEU ILE ALA ALA ALA LYS GLU SEQRES 23 A 289 ALA THR LYS SEQRES 1 B 289 LEU GLU LYS LEU ARG SER ILE VAL SER VAL GLY ASP PRO SEQRES 2 B 289 LYS LYS LYS TYR THR ARG PHE GLU LYS ILE GLY GLN GLY SEQRES 3 B 289 ALA SER GLY THR VAL TYR THR ALA MET ASP VAL ALA THR SEQRES 4 B 289 GLY GLN GLU VAL ALA ILE LYS GLN MET ASN LEU GLN GLN SEQRES 5 B 289 GLN PRO LYS LYS GLU LEU ILE ILE ASN GLU ILE LEU VAL SEQRES 6 B 289 MET ARG GLU ASN LYS ASN PRO ASN ILE VAL ASN TYR LEU SEQRES 7 B 289 ASP SER TYR LEU VAL GLY ASP GLU LEU TRP VAL VAL MET SEQRES 8 B 289 GLU TYR LEU ALA GLY GLY SER LEU THR ASP VAL VAL THR SEQRES 9 B 289 GLU THR CYS MET ASP GLU GLY GLN ILE ALA ALA VAL CYS SEQRES 10 B 289 ARG GLU CYS LEU GLN ALA LEU GLU PHE LEU HIS SER ASN SEQRES 11 B 289 GLN VAL ILE HIS ARG ASN ILE LYS SER ASP ASN ILE LEU SEQRES 12 B 289 LEU GLY MET ASP GLY SER VAL LYS LEU THR ASP PHE GLY SEQRES 13 B 289 PHE CYS ALA GLN ILE THR PRO GLU GLN SER LYS ARG SER SEQRES 14 B 289 GLU MET VAL GLY THR PRO TYR TRP MET ALA PRO GLU VAL SEQRES 15 B 289 VAL THR ARG LYS ALA TYR GLY PRO LYS VAL ASP ILE TRP SEQRES 16 B 289 SER LEU GLY ILE MET ALA ILE GLU MET ILE GLU GLY GLU SEQRES 17 B 289 PRO PRO TYR LEU ASN GLU ASN PRO LEU ARG ALA LEU TYR SEQRES 18 B 289 LEU ILE ALA THR ASN GLY THR PRO GLU LEU GLN ASN PRO SEQRES 19 B 289 GLU LYS LEU SER ALA ILE PHE ARG ASP PHE LEU ASN ARG SEQRES 20 B 289 CYS LEU ASP MET ASP VAL GLU LYS ARG GLY SER ALA LYS SEQRES 21 B 289 GLU LEU LEU GLN HIS GLN PHE LEU LYS ILE ALA LYS PRO SEQRES 22 B 289 LEU SER SER LEU THR PRO LEU ILE ALA ALA ALA LYS GLU SEQRES 23 B 289 ALA THR LYS HET IPV A 601 34 HETNAM IPV [4-METHYL-3-[METHYL-[2-[(3-METHYLSULFONYL-5-MORPHOLIN- HETNAM 2 IPV 4-YL-PHENYL)AMINO]PYRIMIDIN-4-YL]AMINO]PHENYL]METHANOL FORMUL 3 IPV C24 H29 N5 O4 S FORMUL 4 HOH *49(H2 O) HELIX 1 AA1 LEU A 254 SER A 259 1 6 HELIX 2 AA2 ASP A 265 LYS A 269 1 5 HELIX 3 AA3 ASN A 302 GLN A 306 5 5 HELIX 4 AA4 LYS A 309 ASN A 322 1 14 HELIX 5 AA5 LEU A 352 THR A 359 1 8 HELIX 6 AA6 ASP A 362 ASN A 383 1 22 HELIX 7 AA7 LYS A 391 ASP A 393 5 3 HELIX 8 AA8 THR A 427 MET A 431 5 5 HELIX 9 AA9 ALA A 432 THR A 437 1 6 HELIX 10 AB1 LYS A 444 GLY A 460 1 17 HELIX 11 AB2 ASN A 468 GLY A 480 1 13 HELIX 12 AB3 ASN A 486 LEU A 490 5 5 HELIX 13 AB4 SER A 491 LEU A 502 1 12 HELIX 14 AB5 SER A 511 LEU A 516 1 6 HELIX 15 AB6 GLN A 517 ALA A 524 5 8 HELIX 16 AB7 PRO A 526 SER A 529 5 4 HELIX 17 AB8 LEU A 530 THR A 541 1 12 HELIX 18 AB9 GLU B 255 ILE B 260 5 6 HELIX 19 AC1 ASP B 265 LYS B 269 1 5 HELIX 20 AC2 LYS B 308 ASN B 322 1 15 HELIX 21 AC3 SER B 351 THR B 359 1 9 HELIX 22 AC4 ASP B 362 ASN B 383 1 22 HELIX 23 AC5 LYS B 391 ASP B 393 5 3 HELIX 24 AC6 ALA B 432 THR B 437 1 6 HELIX 25 AC7 PRO B 443 GLY B 460 1 18 HELIX 26 AC8 ASN B 468 ASN B 479 1 12 HELIX 27 AC9 SER B 491 LEU B 502 1 12 HELIX 28 AD1 SER B 511 LEU B 516 1 6 HELIX 29 AD2 GLN B 517 ALA B 524 5 8 HELIX 30 AD3 PRO B 526 SER B 529 5 4 HELIX 31 AD4 LEU B 530 THR B 541 1 12 SHEET 1 AA1 5 TYR A 270 GLY A 277 0 SHEET 2 AA1 5 THR A 283 ASP A 289 -1 O VAL A 284 N ILE A 276 SHEET 3 AA1 5 GLU A 295 GLN A 300 -1 O ILE A 298 N TYR A 285 SHEET 4 AA1 5 LEU A 340 GLU A 345 -1 O MET A 344 N ALA A 297 SHEET 5 AA1 5 TYR A 330 LEU A 335 -1 N ASP A 332 O VAL A 343 SHEET 1 AA2 3 GLY A 350 SER A 351 0 SHEET 2 AA2 3 ILE A 395 LEU A 397 -1 O LEU A 397 N GLY A 350 SHEET 3 AA2 3 VAL A 403 LEU A 405 -1 O LYS A 404 N LEU A 396 SHEET 1 AA3 2 VAL A 385 ILE A 386 0 SHEET 2 AA3 2 ALA A 412 GLN A 413 -1 O ALA A 412 N ILE A 386 SHEET 1 AA4 5 TYR B 270 LYS B 275 0 SHEET 2 AA4 5 VAL B 284 ASP B 289 -1 O MET B 288 N THR B 271 SHEET 3 AA4 5 GLU B 295 ASN B 302 -1 O VAL B 296 N ALA B 287 SHEET 4 AA4 5 GLU B 339 GLU B 345 -1 O MET B 344 N ALA B 297 SHEET 5 AA4 5 TYR B 330 VAL B 336 -1 N TYR B 334 O TRP B 341 SHEET 1 AA5 2 ILE B 395 LEU B 397 0 SHEET 2 AA5 2 VAL B 403 LEU B 405 -1 O LYS B 404 N LEU B 396 CISPEP 1 GLN A 278 GLY A 279 0 1.71 CISPEP 2 SER A 419 LYS A 420 0 8.95 SITE 1 AC1 15 ILE A 276 GLY A 277 GLN A 278 ALA A 297 SITE 2 AC1 15 LYS A 299 GLU A 315 VAL A 342 MET A 344 SITE 3 AC1 15 GLU A 345 TYR A 346 LEU A 347 ALA A 348 SITE 4 AC1 15 LEU A 396 THR A 406 LYS A 538 CRYST1 61.911 80.940 66.022 90.00 107.07 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016152 0.000000 0.004960 0.00000 SCALE2 0.000000 0.012355 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015844 0.00000